FDA Approved: ZOKINVY — Original Application (Sentynl Therapeutics, Inc.)

View source ↗

Summary

The FDA approved Zokinvy (lonafarnib) from Sentynl Therapeutics for Hutchinson-Gilford Progeria Syndrome and processing-deficient progeroid syndromes, marking t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hutchinson-gilford Progeria Syndrome
• Processing-deficient Progeroid Syndromes

Drugs mentioned

• Zokinvy (Lonafarnib)

Snippet

ORIG AP for ZOKINVY (LONAFARNIB)